Q3 2026 13F filing
Updated 9 days ago39 disclosed positions worth $629M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KINIKSA PHARMACEUTICALS INTL | $68.5M | 918.1K | 10.89% | — |
| 2 | L LB PHARMACEUTICALS INC | $53.9M | 1.40M | 8.56% | — |
| 3 | R RELAY THERAPEUTICS INC | $53.9M | 2.98M | 8.56% | — |
| 4 | A ALTO NEUROSCIENCE INC | $42.8M | 1.68M | 6.80% | — |
| 5 | A ALKERMES PLC | $38.4M | 948.5K | 6.11% | — |
| 6 | E ENTERA BIO LTD | $32.6M | 11.21M | 5.19% | — |
| 7 | D DIANTHUS THERAPEUTICS INC | $31.2M | 354.8K | 4.97% | — |
| 8 | S SAVARA INC | $27.8M | 5.38M | 4.42% | — |
| 9 | Z ZAI LAB LTD | $27.5M | 1.04M | 4.36% | — |
| 10 | R RELMADA THERAPEUTICS INC | $26.1M | 6.91M | 4.14% | — |
| 11 | P VAXCYTE INC | $17.4M | 306.0K | 2.77% | — |
| 12 | O OBSIDIAN THERAPEUTICS INC | $17.2M | 1.25M | 2.73% | — |
| 13 | E ENLIVEN THERAPEUTICS INC | $15.1M | 329.0K | 2.40% | — |
| 14 | E ENANTA PHARMACEUTICALS INC | $14.3M | 1.09M | 2.28% | — |
| 15 | ? N/A SURROZEN INC | $13.9M | 432.0K | 2.21% | — |
| 16 | S SAGIMET BIOSCIENCES INC | $13.8M | 1.40M | 2.20% | — |
| 17 | Y YARROW BIOSCIENCE INC | $13.7M | 607.4K | 2.17% | — |
| 18 | I INFLARX NV | $11M | 6.09M | 1.74% | — |
| 19 | K KORSANA BIOSCIENCES INC | $10.3M | 339.0K | 1.64% | — |
| 20 | ? N/A PERSPECTIVE THERAPEUTICS INC | $10.2M | 3.69M | 1.61% | — |
| 21 | ? N/A AN2 THERAPEUTICS INC | $9.3M | 1.75M | 1.48% | — |
| 22 | I INHIBIKASE THERAPEUTICS INC | $7.4M | 3.58M | 1.17% | — |
| 23 | S SAB BIOTHERAPEUTICS INC | $7M | 2.20M | 1.11% | — |
| 24 | C CENTURY THERAPEUTICS INC | $6.9M | 4.06M | 1.10% | — |
| 25 | E ERASCA INC | $6.2M | 422.5K | 0.98% | — |
| 26 | A ACHIEVE LIFE SCIENCE INC | $6M | 736.6K | 0.95% | — |
| 27 | N MINERVA NEUROSCIENCES INC | $5.5M | 1.66M | 0.88% | — |
| 28 | R RESEARCH ALLIANCE CORP III | $5.4M | 500.0K | 0.86% | — |
| 29 | R RESEARCH ALLIANCE CORP IV | $5.4M | 450.0K | 0.86% | — |
| 30 | ? N/A HELIX ACQUISITION CORP III | $5.3M | 500.0K | 0.84% | — |
| 31 | ? N/A ATTOVIA THERAPEUTICS INC | $3.9M | 228.3K | 0.62% | — |
| 32 | A ALECTOR INC | $3.9M | 2.10M | 0.62% | — |
| 33 | ? N/A TCGX ACQUISITION CORP | $3.8M | 300.0K | 0.60% | — |
| 34 | ? N/A LEXEO THERAPEUTICS INC | $3.1M | 928.6K | 0.50% | — |
| 35 | A ALUMIS INC | $2.9M | 392.6K | 0.46% | — |
| 36 | C CORVUS PHARMACEUTICALS INC | $2.7M | 231.6K | 0.42% | — |
| 37 | J JATT II ACQUISITION CORP | $1.8M | 160.0K | 0.29% | — |
| 38 | J JATT III ACQUISITION CORP | $1.7M | 150.0K | 0.26% | — |
| 39 | L LEONABIO INC | $1.4M | 393.7K | 0.22% | — |